《癌症免疫治疗杂志》（JITC）是一本开放的、同行评议的杂志，出版了肿瘤免疫和癌症免疫治疗的各个方面，旨在丰富交流，促进这一快速发展领域的科学理解。感兴趣的主题涵盖基础科学转化临床谱，包括肿瘤宿主相互作用、肿瘤微环境、动物模型、预测和预后免疫生物标志物、新型药物和细胞疗法、疫苗、基于免疫的组合疗法以及免疫相关毒性。
Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed journal that publishes on all aspects of tumor immunology and cancer immunotherapy, aiming to enrich communication and advance scientific understanding in this rapidly evolving field. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.
* 请认真填写需求信息，学术顾问24小时内与您取得联系。
投稿咨询